2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart …
JA Joglar, MK Chung, AL Armbruster, EJ Benjamin… - Circulation, 2024 - Am Heart Assoc
AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …
G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
P Kirchhof, S Benussi, D Kotecha… - Polish Heart …, 2016 - journals.viamedica.pl
Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …
Mobile health technology to improve care for patients with atrial fibrillation
Y Guo, DA Lane, L Wang, H Zhang, H Wang… - Journal of the American …, 2020 - jacc.org
Background Current management of patients with atrial fibrillation (AF) is limited by low
detection of AF, non-adherence to guidelines, and lack of consideration of patients' …
detection of AF, non-adherence to guidelines, and lack of consideration of patients' …
[HTML][HTML] Фибрилляция и трепетание предсердий. Клинические рекомендации 2020
МГ Аракелян, ЛА Бокерия, ЕЮ Васильева… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …
Modifiable risk factors and atrial fibrillation
There has been increasing focus on the rising burden of atrial fibrillation (AF) since the turn
of the millennium. The AF epidemic is projected not only to have an impact on morbidity and …
of the millennium. The AF epidemic is projected not only to have an impact on morbidity and …
[HTML][HTML] 2020 Clinical guidelines for Atrial fibrillation and atrial flutter
MG Arakelyan, LA Bockeria… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
clinical guidelines, atrial fibrillation, ischemic stroke, anticoagulant therapy, vitamin K
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial …
D Brieger, J Amerena, JR Attia… - Medical Journal of …, 2018 - Wiley Online Library
Introduction: Atrial fibrillation (AF) is increasing in prevalence and is associated with
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …
[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
F Casselman, A Coca, R De Caterina… - European heart …, 2016 - academia.edu
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …
is recommended in the guidelines, thus completing the loop between clinical research …
Adherence to oral anticoagulant therapy in patients with atrial fibrillation
Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular
atrial fibrillation (NVAF) patients. Effective anticoagulation is important to avoid major …
atrial fibrillation (NVAF) patients. Effective anticoagulation is important to avoid major …